Kinney Gene G. has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 520000 shares of PROTHENA CORP PUBLIC LTD CO ($PRTA) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Kinney Gene G. | President and CEO | A | Stock Option (Right to Buy) | 520000 | $0.00 | 520,000.0000 | 53,830,000 | 9999.99% | 0.97% |
| July 28, 2025 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Kinney Gene G. | President and CEO | A | Ordinary Shares, par value $0.01 per share | 140000 | $0.00 | 152,793.0000 | 53,772,000 | 1094.35% | 0.26% |
| March 5, 2025 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Kinney Gene G. | President and CEO | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 53,772,000 | 9999.99% | 0.70% |
| Feb. 27, 2024 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Kinney Gene G. | President and CEO | A | Stock Option (Right to Buy) | 307000 | $0.00 | 307,000.0000 | 53,216,000 | 9999.99% | 0.58% |